DHAKA: The US Food and Drug Administration (FDA) has approved a libido-enhancing drug for women that has been dubbed ‘Female Viagra’.

Flibanserin, a drug produced by Sprout Pharmaceuticals, recently passed an FDA advisory committee meeting.

The pill is designed to assist premenopausal women regain their sex drive by boosting levels of certain brain chemicals.

The drug has been criticized as having marginal effects.

Versions of the pill, which will be marketed as ‘Addyi’, have been submitted for approval in the past but never passed.

It was rejected by the FDA twice for lack of effectiveness and side effects like nausea, dizziness and fainting.

Women taking the drug reported between half and one more sexually satisfying event per month - results experts admitted were ‘modest’.

Originally the drug was produced by German company Boehringer Ingelheim. Sprout bought the drug from that company after it was turned down by the FDA.

BDST: 1333 HRS, AUG 19, 2015
RR